IVERMEKTIN – really (un)effective?

Please note its no COVID-prophylactic effects and influential liver injuring enervation when (over)dosed without medical attentions

IVERMEKTIN effectivenessBritish
original
British
E484K
Sth.African
B.1.351
Brasil
P.1 a P.2
Indian
“two-ply”
B.1.617
mutation infectiousness twicefourfivefour
Prophylactic effects
hcy < 30,0 mmol 0 %0 %O %0 %0 %
Medical effects
used following 2 days after infection
hcy 25 – 30,0 mmol74 % 50 %34 %30 % 0 %
hcy 15 – 24,9 mmol64 %49 %33 %28 %0 %
hcy < 15,0 mmol61 %49 %33 %28 %0 %
used following 3 days after infection
hcy 25 – 30,0 mmol55 %48 %34 %30 %0 %
hcy 15 – 24,9 mmol55 %47 %25 %27 %0 %
hcy < 15,0 mmol57 %37 %5 %3 %0 %
used following 5 days after infection
hcy 25 – 30,0 mmol38 %27 %16 %8 %0 %
hcy 15 – 24,9 mmol14 %9 %5 %0 %0 %
hcy < 15,0 mmol3 %2 %1 %0 %0 %
used following 10 days after infection
hcy 25 – 30,0 mmol16 %3 %1 %0 %0 %
hcy 15 – 24,9 mmol9 %0 %0 %0 %0 %
hcy < 15,0 mmol5 %0 %0 %0 %0 %
Legend:
Hcy – homocysteine level mmol / litr
Source: regenea.eu, not EBM